APA (7th ed.) Citation

Zhang, D., Wen, J., Dong, J., Ma, R., Li, S., Wu, J., . . . Sun, X. (2025). Evaluating the efficacy of basiliximab versus no induction in low-immunological-risk kidney transplant recipients: A propensity score matched analysis. Renal Failure, 47(1), 1. https://doi.org/10.1080/0886022X.2025.2460729

Chicago Style (17th ed.) Citation

Zhang, Dahao, et al. "Evaluating the Efficacy of Basiliximab Versus No Induction in Low-immunological-risk Kidney Transplant Recipients: A Propensity Score Matched Analysis." Renal Failure 47, no. 1 (2025): 1. https://doi.org/10.1080/0886022X.2025.2460729.

MLA (9th ed.) Citation

Zhang, Dahao, et al. "Evaluating the Efficacy of Basiliximab Versus No Induction in Low-immunological-risk Kidney Transplant Recipients: A Propensity Score Matched Analysis." Renal Failure, vol. 47, no. 1, 2025, p. 1, https://doi.org/10.1080/0886022X.2025.2460729.